Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Treated with Isatuximab Plus Pomalidomide and Dexamethasone: Icaria-MM Study
Blood (2019) 134 (Supplement_1): 1850.
Currently there are no citedby results. Try again later.
